Pharmacological Profile and Ocular Hypotensive Effects of Cromakalim Prodrug 1, a Novel ATP-Sensitive Potassium Channel Opener, in Normotensive Dogs and Nonhuman Primates-Reference-Cited by-同舟云学术

Pharmacological Profile and Ocular Hypotensive Effects of Cromakalim Prodrug 1, a Novel ATP-Sensitive Potassium Channel Opener, in Normotensive Dogs and Nonhuman Primates

Published:2021-06-01 Issue:5 Volume:37 Page:251-260
ISSN:1080-7683
Container-title:Journal of Ocular Pharmacology and Therapeutics
language:en
Short-container-title:Journal of Ocular Pharmacology and Therapeutics

Author:

Roy Chowdhury Uttio¹,Kudgus Rachel A.²,Holman Bradley H.¹,Rinkoski Tommy A.¹,Hann Cheryl R.¹,Bahler Cindy K.¹,McCloud Eric³,Appt Susan E.³,Reid Joel M.²,Dosa Peter I.⁴,Fautsch Michael P.¹

Affiliation:

1. Department of Ophthalmology, Mayo Clinic Rochester, Rochester, Minnesota, USA.

2. Department of Oncology Research, Mayo Clinic Rochester, Rochester, Minnesota, USA.

3. Department of Pathology, Section of Comparative Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.

4. Department of Medicinal Chemistry, Institute for Therapeutics Discovery and Development, University of Minnesota, Minneapolis, Minnesota, USA.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmacology,Ophthalmology

Link

https://www.liebertpub.com/doi/pdf/10.1089/jop.2020.0137

Reference36 articles.

1. The Pathophysiology and Treatment of Glaucoma

2. Primary open-angle glaucoma

3. Rate of Response to Latanoprost or Timolol in Patients With Ocular Hypertension or Glaucoma

4. A Retrospective Review of Non-Responders to Latanoprost

5. The Effects of Topical Antiglaucoma Drugs as Monotherapy on the Ocular Surface: A Prospective Study

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between dietary calcium, potassium, and magnesium consumption and glaucoma;PLOS ONE;2023-10-18

2. Identifying new drugs and targets to treat rapidly elevated intraocular pressure for angle closure and secondary glaucomas to curb visual impairment and prevent blindness;Experimental Eye Research;2023-07

3. Preclinical Pharmacokinetic Profile of Topical Ophthalmic and Intravenous Delivery of QLS-101, a Novel ATP-Sensitive Potassium Channel Opening Ocular Hypotensive Agent;Journal of Ocular Pharmacology and Therapeutics;2023-06-01

4. K_ATPChannel Prodrugs Reduce Inflammatory and Neuropathic Hypersensitivity, Morphine-Induced Hypersensitivity, and Precipitated Withdrawal in Mice;Journal of Pharmacology and Experimental Therapeutics;2023-03-17

5. New Glaucoma Medications;International Ophthalmology Clinics;2023